Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/89/45/15/894515df-8cf9-1503-7f86-69eb52e6baea/mza_1769051247888600121.jpg/600x600bb.jpg

The Studio at Kendall Square

BiotechTV

20 episodes

1 week ago

The Studio at Kendall Square is a video podcast studio built by BiotechTV and MassBio at MassBio's headquarters in Tech Square at Kendall Square. It is a platform for the Boston biotech community to use and have your podcast discussions recorded in-person and then broadcast on BiotechTV. The studio will give voice to the vast network of experts who live in and around 'The Most Innovative Square Mile on the Planet'.

Life Sciences

Science

RSS

All content for The Studio at Kendall Square is the property of BiotechTV and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43071135/43071135-1739796966513-fa43c2fbf2456.jpg

Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis

The Studio at Kendall Square

24 minutes 16 seconds

1 year ago

Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis

Dr. Excoffon describes her academic experience that led her to the field and Spirovant Sciences, discusses interesting data from last month’s North American Cystic Fibrosis Conference, and then highlights Spirovant’s program and why using a small molecule modulator like doxorubicin might be the key to success.